CivicaScript Expands Affordable Medication Offerings
The company's latest move aims to improve access to critical healthcare solutions.
CivicaScript, LLC, a nonprofit organization committed to providing low-cost medications, has made an exciting announcement. They have introduced two new products to their ever-growing portfolio: insulin glargine-yfgn and ustekinumab-aauz. These additions emphasize their dedication to ensuring that essential medications are accessible and affordable for patients across the United States.
Features of Insulin Glargine-yfgn
Insulin glargine-yfgn plays a vital role in managing diabetes. It is specifically designed to enhance glycemic control in both adult and pediatric patients dealing with diabetes mellitus. This product is interchangeable with Lantus, meaning it can be used as an effective alternative to existing treatments. CivicaScript collaborated with multiple partners to bring affordable insulin to those in need.
This innovative insulin is marketed nationwide by CivicaScript. In California, it will be available under the CalRx brand through a partnership with the state's CalRx program, furthering its commitment to making medications accessible.
Availability and Pricing of Ustekinumab-aauz
The second exciting product, ustekinumab-aauz, is aimed at treating various chronic inflammatory conditions. This medication helps patients battling plaque psoriasis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis. Like insulin glargine-yfgn, it is also interchangeable with its reference product, Stelara, providing patients with more affordable treatment options.
Pricing transparency is a core value for CivicaScript. The company is offering ustekinumab-aauz at a low and transparent cost of $985 for a 12-week supply of 90 mg and $575 for a 12-week supply of 45 mg. These prices reflect CivicaScript's commitment to making medications available at a lower cost compared to traditional pharmaceutical options.
Commitment to Patient-Centric Care
Brent J. Eberle, the President of CivicaScript, expresses pride in the company's ability to provide these necessary medications, stating, "By expanding access to biosimilars that help lower costs, we are truly putting patients first. It’s not just an ideal; it’s a proven method for delivering affordable healthcare solutions." This patient-centric approach has always been a driving force behind the mission of CivicaScript.
CivicaScript's price point for insulin glargine-yfgn is particularly notable. With the lowest list price in the long-acting insulin market, CivicaScript offers pharmacies a box of five pens for just $45. The company's maximum recommended price for consumers caps at $55, and it could even be lower based on individual insurance plans. This creates a stark contrast to existing drug pricing models, which often rely on complicated copay assistance programs that can confuse patients.
About CivicaScript
CivicaScript aims to revolutionize the pharmaceutical supply chain, providing transparency in medication costs. As a not-for-profit entity, CivicaScript focuses on delivering affordable, high-quality generic medicines and biosimilars, ensuring that essential medications are always available. This mission promotes the health and well-being of communities across the nation.
Understanding the Medications
Insulin Glargine-yfgn
It is important for patients to understand how to use insulin glargine-yfgn correctly. It should not be diluted or mixed with other insulins or solutions, as this can alter the medication's effects. Additionally, insulin glargine-yfgn must not be administered through insulin pumps or intravenously to avoid the risk of hypoglycemia.
Ustekinumab-aauz
Ustekinumab-aauz is designated for patients with chronic inflammatory conditions. However, it is essential to note that this medication is contraindicated for individuals with significant hypersensitivity to any of its components. Patients should always consult healthcare professionals for comprehensive details about potential side effects and contraindications.
Frequently Asked Questions
What is CivicaScript's mission?
CivicaScript is dedicated to providing affordable and quality generic medicines to enhance patient access and improve public health outcomes.
Where can I find insulin glargine-yfgn?
This product is available through pharmacies across the U.S., and specifically branded as CalRx in California.
How does ustekinumab-aauz benefit patients?
Ustekinumab-aauz helps manage chronic inflammatory conditions, providing patients with a cost-effective alternative to existing treatments.
Why is pricing transparency important?
Transparent pricing helps patients make informed decisions about their healthcare and reduces the unpredictability associated with medication costs.
How does CivicaScript impact drug affordability?
By offering lower-priced alternatives to brand-name medications, CivicaScript significantly lowers the financial burden on patients and healthcare systems alike.
